Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about IONS

Recent news which mentions IONS

< Previous 1 2 3 4 5 6 Next >
12 Analysts Have This To Say About Ionis Pharmaceuticals
Tickers IONS
Tags BZI/AAR Market News Analyst Ratings
From Benzinga
Ionis' Rare Development Disorder Drug Candidate 'Could Be Differentiated' From Peer Ultragenyx: Analyst
Tickers ALNY AZN BIIB IONS
Tags Briefs IONS News
From Benzinga
The Latest Analyst Ratings For Ionis Pharmaceuticals
Tickers IONS
Tags BZI/AAR Analyst Ratings Market News
From Benzinga
Assessing Ionis Pharmaceuticals: Insights From 6 Financial Analysts
Tickers IONS
Tags BZI/AAR Analyst Ratings Market News
From Benzinga
RXO, Alnylam Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Tickers ALNY ALT ARGX CLOV
Tags Movers PHAR RXO
From Benzinga
Deep Dive Into Ionis Pharmaceuticals Stock: Analyst Perspectives (6 Ratings)
Tickers IONS
Tags Analyst Ratings Market News BZI/AAR
From Benzinga
Ionis Pharmaceuticals Reveals Late-Stage Donidalorsen Data, Analyst Says Results Show Competitive Hereditary Angioedema Profile
Tickers IONS NEWS
Tags Health Care Benzinga Biotech
From Benzinga
Europe Approves Biogen's Tofersen For Adult Patients With Rare Type Of Neurodegenerative Disorder
Tickers BIIB IONS NEWS
Tags Market News Biotech Benzinga
From Benzinga
Tale Of Two Ionis-Partnered Neurology-Focused Early Stage Assets-Biogen Discontinues One, Decides Not To Exercise Licensing Option For Another
Tickers BIIB IONS NEWS
Tags Equities Movers General
From Benzinga
The 3 Most Undervalued Pharma Stocks to Buy in May 2024
Tickers BIIB IONS SNY
Tags NASDAQ:IONS,NASDAQ:SNY,NASDAQ:BIIB Stocks to Buy IONS
From InvestorPlace
The Analyst Landscape: 8 Takes On Ionis Pharmaceuticals
Tickers IONS
Tags Benzinga IONS Analyst Ratings
From Benzinga
IONS Stock Earnings: Ionis Pharmaceuticals Beats EPS, Misses Revenue for Q1 2024
Tickers IONS
Tags Earnings Reports IONS Market News
From InvestorPlace
The Latest Analyst Ratings For Ionis Pharmaceuticals
Tickers IONS
Tags Benzinga IONS BZI/AAR
From Benzinga
Genetic Medicines Focused-Ionis Pharmaceuticals' Fatty Liver Candidate Lowers Excess Liver Fat, Midstage Study Data Shows
Tickers IONS NEWS
Tags Briefs IONS News
From Benzinga
Cracking The Code: Understanding Analyst Reviews For Ionis Pharmaceuticals
Tickers IONS
Tags Analyst Ratings Market News BZI/AAR
From Benzinga
Earnings Scheduled For February 21, 2024
Tickers ACVA ADI AGI AGR
Tags JXN GIL MGRC
From Benzinga
JP Morgan Maintains Neutral Rating for Ionis Pharmaceuticals: Here's What You Need To Know
Tickers IONS
Tags Benzinga IONS BZI/AAR/UPDATE
From Benzinga
Biogen Gives Up On Aduhelm Efforts After Two Years Of Controversial FDA Accelerated Approval For Alzheimer's, Shifts Focus On Newer Medicines
Tickers BIIB IONS NEWS
Tags pharmaceuticals BIIB IONS
From Benzinga
Rare Disease Focused Ionis Pharmaceuticals Gears Up for FDA Submission After Donidalorsen Outperforms Placebo In Swollen Vessels Study
Tickers IONS NEWS
Tags Reiteration Analyst Ratings Market News
From Benzinga
Expert Outlook: Ionis Pharmaceuticals Through The Eyes Of 8 Analysts
Tickers IONS
Tags BZI/AAR Analyst Ratings Market News
From Benzinga
2024 And Beyond – Exploring Six Investment Megatrends With Tema ETFs
Tickers ALNY ARM CPRI IONS
Tags MCO tema etfs TPR
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Tickers ABBV ALNY CVS GILD
Tags BZI/AUOA PFE MRNA
From Benzinga
3 Stocks to Buy Now Before They Become Tomorrow’s Trillion-Dollar Companies
Tickers IONS TSM UNH
Tags NASDAQ:IONS,NYSE:UNH,NYSE:TSM IONS TSM
From InvestorPlace
Pricing Projections And Market Potential For Ionis' Newly Approved Nerve Damage Drug - Analyst Sees Over $700M Potential
Tickers ALNY AZN IONS NEWS
Tags ALNY Analyst Ratings Market News
From Benzinga
New Hope for Nerve Damage Patients as AstraZeneca/Ionis' Eplontersen Receives FDA Nod for Hereditary Amyloidosis Treatment
Tickers AZN IONS NEWS
Tags Large Cap Movers General
From Benzinga
Ionis' Strategic Shift Praised by Analysts For Donidalorsen's Global Reach
Tickers IONS TAK
Tags Analyst Color Expert Ideas General
From Benzinga
Where Ionis Pharmaceuticals Stands With Analysts
Tickers IONS
Tags Benzinga IONS Analyst Ratings
From Benzinga
Cathie Wood's Ark Invest Goes Shopping For Moderna Stock — Sells DraftKings Shares Amid Quarterly Rise In Revenue, EPS Beat
Tickers ARKG ARKK ARKQ DKNG
Tags Covid/19 ARK Invest Market News
From Benzinga
Analyst Expectations for Ionis Pharmaceuticals's Future
Tickers IONS
Tags Benzinga IONS Market News
From Benzinga
Cathie Wood-Led Ark Invest Sells Over $6.5M Worth Of Tesla Stock, What's Going On?
Tickers ARKG ARKK CRSP EVS
Tags Benzinga Ark Invest Management CRSP
From Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.